These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7772678)

  • 1. Angiotensin-converting enzyme inhibition reduces diabetes-induced vascular hypertrophy: morphometric studies.
    Vranes D; Cooper ME; Dilley RJ
    J Vasc Res; 1995; 32(3):183-9. PubMed ID: 7772678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition.
    Cooper ME; Rumble J; Komers R; Du HC; Jandeleit K; Chou ST
    Diabetes; 1994 Oct; 43(10):1221-8. PubMed ID: 7926292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: morphological and molecular biological studies.
    Cooper ME; Cao Z; Rumble JR; Jandeleit K; Allen TJ; Gilbert RE
    Metabolism; 1998 Dec; 47(12 Suppl 1):24-7. PubMed ID: 9867067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
    Rumble JR; Komers R; Cooper ME
    J Hypertens; 1996 May; 14(5):601-7. PubMed ID: 8762203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular changes in the diabetic kidney: effects of ACE inhibition.
    Vranes D; Dilley RJ; Cooper ME
    J Diabetes Complications; 1995; 9(4):296-300. PubMed ID: 8573751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
    Black MJ; Kanellakis P; Bobik A
    J Hypertens; 1997 Sep; 15(9):945-54. PubMed ID: 9321741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms of diabetic vascular hypertrophy.
    Vranes D; Cooper ME; Dilley RJ
    Microvasc Res; 1999 Jan; 57(1):8-18. PubMed ID: 9882558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action.
    Cao Z; Hulthén UL; Allen TJ; Cooper ME
    J Hypertens; 1998 Jun; 16(6):793-9. PubMed ID: 9663919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model.
    Dhein S; Hochreuther S; Aus Dem Spring C; Bollig K; Hufnagel C; Raschack M
    J Pharmacol Exp Ther; 2000 May; 293(2):351-9. PubMed ID: 10773002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
    Yan L; Yang R; Cheng H; Fu Z; Zhong G; Yan T
    Chin Med J (Engl); 1998 Apr; 111(4):306-8. PubMed ID: 10374392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
    Devlin AM; Gordon JF; Davidson AO; Clark JS; Hamilton CA; Morton JJ; Campbell AM; Reid JL; Dominiczak AF
    J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin inhibits mesenteric vascular hypertrophy in angiotensin II-infusion hypertension in rats.
    Dilley RJ; Nataatmadja MI
    Cardiovasc Res; 1998 Apr; 38(1):247-55. PubMed ID: 9683928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy and diabetic microvascular disease.
    Cooper ME
    Clin Exp Hypertens; 1997; 19(5-6):769-78. PubMed ID: 9247754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of perindopril: from experimental to clinical investigation.
    Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathy.
    Rumble JR; Gilbert RE; Cox A; Wu L; Cooper ME
    J Hypertens; 1998 Nov; 16(11):1603-9. PubMed ID: 9856360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin-converting enzyme inhibitor, perindopril, prevents cardiac hypertrophy in low-renin hypertensive rats.
    Nakamura F; Nagano M; Higaki J; Higashimori K; Morishita R; Mikami H; Ogihara T
    Clin Exp Pharmacol Physiol; 1993 Mar; 20(3):135-40. PubMed ID: 8467569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.
    Duncan AM; Burrell LM; Kladis A; Campbell DJ
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):746-54. PubMed ID: 8961071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition.
    Jandeleit-Dahm K; Hannan KM; Farrelly CA; Allen TJ; Rumble JR; Gilbert RE; Cooper ME; Little PJ
    Circ Res; 2000 Dec; 87(12):1133-40. PubMed ID: 11110770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries.
    Michel JB; Heudes D; Michel O; Poitevin P; Philippe M; Scalbert E; Corman B; Levy BI
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R124-35. PubMed ID: 8048614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.